Cameron Turtle, CEO: Spyre Therapeutics SYRE Planned sale · Filed 25/11/03

Trade details

Type: Planned sale notice
Stock: Spyre Therapeutics SYRE
Person: Cameron TurtleCEO
Planned sale date: 25/11/03
Filed: 25/11/03

0.1% of shares outstanding to be sold

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/04~25/12/03

Cameron Turtle's recent trades

Cameron TurtleCEO
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$4M
45,000 sh
$4M
Filed 10/01
Traded 10/01
Cameron TurtleCEO
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$4M
45,000 sh
$4M
Filed 07/01
Traded 07/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$574.5K
8,149 sh
$574.5K
Filed 06/03
Traded 06/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$246.9K
3,557 sh
$246.9K
Filed 06/03
Traded 06/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$235.1K
3,294 sh
$235.1K
Filed 06/03
Traded 06/01

Cameron Turtle, CEO — plans to sell 90,000 sh of Spyre Therapeutics SYRE · $2.2M · around 11/03 · 10b5-1 plan | Whalegun